BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27774607)

  • 21. The incidence and characteristics of some paraneoplastic syndromes of hepatocellular carcinoma in Nigerian patients.
    Ndububa DA; Ojo OS; Adetiloye VA; Rotimi O; Durosinmi MA; Uchegbu LO
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1401-4. PubMed ID: 10654801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.
    Wang J; Hayashi Y; Yokota A; Xu Z; Zhang Y; Huang R; Yan X; Liu H; Ma L; Azam M; Bridges JP; Cancelas JA; Kalfa TA; An X; Xiao Z; Huang G
    Haematologica; 2018 Jan; 103(1):40-50. PubMed ID: 29051279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia.
    Ross JS; Kurian S
    Am J Gastroenterol; 1985 Mar; 80(3):188-94. PubMed ID: 2983534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythropoietin in hepatocellular carcinoma].
    Malaguarnera M; Bentivegna P; Di Fazio I; Laurino A; Romano M; Trovato BA
    Bull Cancer; 1996 Dec; 83(12):977-80. PubMed ID: 9116377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.
    Wiesener MS; Seyfarth M; Warnecke C; Jürgensen JS; Rosenberger C; Morgan NV; Maher ER; Frei U; Eckardt KU
    Blood; 2002 May; 99(10):3562-5. PubMed ID: 11986208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocytosis in a patient with hepatocellular carcinoma.
    Trotter JF; Cohn A; Grant R
    J Clin Gastroenterol; 2002 Oct; 35(4):365-6. PubMed ID: 12352309
    [No Abstract]   [Full Text] [Related]  

  • 27. A man with a deltoid swelling and paraneoplastic erythrocytosis: case report.
    Alimonti A; Di Cosimo S; Maccallini V; Ferretti G; Pavese I; Satta F; Di Palma M; Vecchione A
    Anticancer Res; 2003; 23(6D):5181-4. PubMed ID: 14981986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complete evaluation of erythrocytosis: congenital and acquired.
    Patnaik MM; Tefferi A
    Leukemia; 2009 May; 23(5):834-44. PubMed ID: 19295544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma associated with erythrocytosis. A nine year survival after successful chemotherapy and left lateral hepatectomy.
    Okazaki N; Ozaki H; Arima M; Hattori N; Kimura K
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):248-52. PubMed ID: 225917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.
    Percy MJ; Beer PA; Campbell G; Dekker AW; Green AR; Oscier D; Rainey MG; van Wijk R; Wood M; Lappin TR; McMullin MF; Lee FS
    Blood; 2008 Jun; 111(11):5400-2. PubMed ID: 18378852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrocytosis associated with hyperthyroidism: a rare case report and clinical study of possible mechanism.
    Liu X; Liu J; Fan L; Shi B
    Endocr Res; 2015; 40(4):177-80. PubMed ID: 25775381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production.
    Faquin WC; Schneider TJ; Goldberg MA
    Exp Hematol; 1993 Mar; 21(3):420-6. PubMed ID: 7679999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.
    Legros L; Pascale A; Guettier C; Eftekhari P; Merabet YB; Stang M; Bossevot R; Goldschmidt E; Ulusakarya A; Morisset S; Lewin M; Samuel D; Rosmorduc O
    Cancer Chemother Pharmacol; 2023 Apr; 91(4):337-344. PubMed ID: 36961524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells.
    Yoshioka K; Thompson J; Miller MJ; Fisher JW
    Biochem Biophys Res Commun; 1997 Mar; 232(3):702-6. PubMed ID: 9126339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
    Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycemia and erythrocytosis associated with hepatoma.
    Bundith V; Chandraprasert S; Sriratanaban A
    J Med Assoc Thai; 1972 Feb; 55(2):110-5. PubMed ID: 4335655
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe Deoxyguanosine Kinase Deficiency in Austria: A 6-Patient Series.
    Waich S; Roscher A; Brunner-Krainz M; Cortina G; Köstl G; Feichtinger RG; Entenmann A; Müller T; Knisely AS; Mayr JA; Janecke AR; Vodopiutz J
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):e1-e6. PubMed ID: 30589726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
    Roby KA; Beech J; Bloom JC; Black M
    J Am Vet Med Assoc; 1990 Feb; 196(3):465-7. PubMed ID: 2153651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
    Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma and erythrocytosis.
    Davidson CS
    Semin Hematol; 1976 Apr; 13(2):115-9. PubMed ID: 180613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.